Cumberland Pharmaceuticals (CPIX) EBT: 2009-2025
Historic EBT for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$1.9 million.
- Cumberland Pharmaceuticals' EBT fell 27.39% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year increase of 68.68%. This contributed to the annual value of -$6.5 million for FY2024, which is 2.89% down from last year.
- Per Cumberland Pharmaceuticals' latest filing, its EBT stood at -$1.9 million for Q3 2025, which was down 166.39% from -$729,536 recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' EBT registered a high of $1.3 million during Q1 2025, and its lowest value of -$6.3 million during Q4 2023.
- In the last 3 years, Cumberland Pharmaceuticals' EBT had a median value of -$1.1 million in 2024 and averaged -$1.3 million.
- Per our database at Business Quant, Cumberland Pharmaceuticals' EBT slumped by 1,155.12% in 2024 and then spiked by 166.31% in 2025.
- Over the past 5 years, Cumberland Pharmaceuticals' EBT (Quarterly) stood at -$4.4 million in 2021, then spiked by 44.88% to -$2.4 million in 2022, then tumbled by 160.29% to -$6.3 million in 2023, then soared by 68.80% to -$2.0 million in 2024, then fell by 27.39% to -$1.9 million in 2025.
- Its EBT stands at -$1.9 million for Q3 2025, versus -$729,536 for Q2 2025 and $1.3 million for Q1 2025.